【Introduction】
Product Name: Human IL-22 Antibody (Fezakinumab, Research Use)
Catalog Number: NBR-0219
Target Name: IL-22
Trade Name: Fezakinumab
Antibody Drug Description: Fezakinumab is a human monoclonal antibody against interleukin-22, designed for the treatment of psoriasis and rheumatoid arthritis.
【Description】
Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS:N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG
【Gene Information】
Gene Name: IL-22
Synonyms: Interleukin 22
Target Description: Cytokine that contributes to the inflammatory response in vivo.
Ensembl: ENSG00000127318
Uniprot: Q9GZX6